Today, the Federal Trade Commission (FTC) sent warning letters to 10 drug manufacturers challenging the “junk listings” of more than 300 patents in the FDA Orange Book for medicines treating diabetes, weight loss, asthma, and COPD. These letters follow FTC challenges to improper Orange Book (...)
Site référencé: Common Dreams
Common Dreams
15 States Enact Laws to Regulate AI Deepfakes in Elections
20/05/2024
Ungaggable : Costumed Clowns and Lickspittle Surrogates 'R Us
18/05/2024
EPA : $1.3 Trillion Needed for Nation’s Water Infrastructure
15/05/2024
The 2024 Class of Gaza : The Students Have Done Their Part
15/05/2024
IRS Should Make Direct File Permanent, Available Nationwide, More Than 250 Groups Said
14/05/2024
Lobbying to Influence Legislation Including Farm Bill Tops $500 Million
13/05/2024
